Unique ID issued by UMIN | UMIN000029415 |
---|---|
Receipt number | R000033044 |
Scientific Title | Open-Label Study for reduction of brain amyloid beta (Abeta) by removal of blood Abeta in Alzheimer's Disease |
Date of disclosure of the study information | 2017/11/01 |
Last modified on | 2021/04/07 12:20:07 |
Open-Label Study for reduction of brain amyloid beta (Abeta) by removal of blood Abeta in Alzheimer's Disease
Open-Label Study for brain Abeta reduction by blood Abeta removal
Open-Label Study for reduction of brain amyloid beta (Abeta) by removal of blood Abeta in Alzheimer's Disease
Open-Label Study for brain Abeta reduction by blood Abeta removal
Japan |
Alzheimer's Disease, Mild Cognitive Impairment
Nephrology | Neurology | Psychiatry |
Others
NO
To clarify the effect of blood Abeta removal on brain Abeta in mild Alzheimer's disease and MCI patients
Efficacy
Change of brain A beta measured by PIB/PET
from the starting point to the end of sequential treatments of blood A beta removal
Change of cognitive functions measured by MMSE,WMS-R, GDS, and ADAS-JCog, from the starting point to the end of sequential treatments of blood Abeta removal
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Device,equipment |
Removal of blood Abeta by apheresis
1) Devices for Abeta removal from the blood;
1-1) hexadecyl alkylated cellulose beads (HDC),
1-2) dialyzers made of polysulfone (PSf) or polyethersulfone (PES)
2) blood purification period; 1-3 hr
3) Protocol
3-1) Protocol A; 1 session/week x 24w. One or two series.
3-2) Protocol B; 1 session/week x 12w + 1/month x 9M
40 | years-old | <= |
85 | years-old | >= |
Male and Female
Non diabetic MCI/mild AD patients whose Abeta deposition in the brain is confirmed by PIB/PET
1) diabetic patients
2) abnormal numbers of platelets or erythrocytes
3) with complications of severe circulatory or cardiac disorders
4) past medical history of cerebrovascular disease (infarction, bleeding etc.)
5) others whom the principal investigator decides to exclude
6
1st name | Yukio |
Middle name | |
Last name | Yuzawa |
Fujita Health University
Department of Nephrology, School of Medicine
470-1192
1-98 Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan,
0562-93-2353
yukio-y@fujita-hu.ac.jp
1st name | Kazunori |
Middle name | |
Last name | 1. Kazunori Kawaguchi 2. Midori Hasegawa |
Fujita Health University
1,3. Faculty of Clinical Engineering, School of Health Sciences, 2. Department of Nephrology, School
470-1192
1-98 Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan,
0562-93-2619
kkawagu@fujita-hu.ac.jp
Department of Nephrology, School of Medicine, Fujita Health University
Ministry of Education, Culture, Sports, Science and Technology
Japanese Governmental office
Institutional Review Board of Fujita Health University
1-98 Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan,
0562-93-2865
f-irb@fujita-hu.ac.jp
NO
2017 | Year | 11 | Month | 01 | Day |
Unpublished
Terminated
2017 | Year | 10 | Month | 03 | Day |
2017 | Year | 08 | Month | 16 | Day |
2017 | Year | 11 | Month | 01 | Day |
2025 | Year | 03 | Month | 31 | Day |
2025 | Year | 03 | Month | 31 | Day |
2025 | Year | 03 | Month | 31 | Day |
2026 | Year | 03 | Month | 31 | Day |
2017 | Year | 10 | Month | 04 | Day |
2021 | Year | 04 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033044
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |